Form D Filing: Entegrion $5.00 million Fundraising. Susan Reyer Submitted Oct 17 form D

Biotechnology Entegrion Inc - Susan Reyer

Entegrion Financing

Entegrion Inc, Corporation just had published form D regarding $5.00 million debt financing. The date of first sale was 2015-10-23. Entegrion was able to fundraise $4.20 million. That is 84.00% of the financing offer. The total private offering amount was $5.00 million. This form was filed on 2016-10-17. The reason for the financing was: Proceeds will be used for working capital, which will include normal compensation to executive officers.. The fundraising still has about $800,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Entegrion is based in North Carolina. The company’s business is Biotechnology. The SEC form was filed by Susan Reyer Chief Financial Officer. The company was incorporated more than five years ago. The filler’s address is: 79 Tw Alexander Dr, 4401 Research Common Suite 200, Research Triangle Park, Nc, North Carolina, 27709. Richard Martin is the related person in the form and it has address: 79 Tw Alexander Drive, 4401 Research Common Suite 200, Research Triangle Park, Nc, North Carolina, 27709. Link to Entegrion Filing: 000139225316000006.

Analysis of Entegrion Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering size. Entegrion sold 84.00% of the offering. The financing is still open. Could this mean that the trust in Entegrion is high? The average investment size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 36.36% bigger than the average for companies in the Biotechnology sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Entegrion Also

The Form D signed by Susan Reyer might help Entegrion Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment